STC-103

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSTC-103

Drug Alias NameFc fusion protein therapeutic (STC Biologics)STC-103

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesStc Biologics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesStc Biologics

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A